CAMP:NASDAQ
CAMP4 Therapeutics Corp
$4.34
arrow_upward
+0.23%(+0.010) 1D
$4.34
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 10, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CAMP...
Open
$4.30
High
$4.50
Low
$4.14
Mkt. cap
272.35M
Avg. vol.
269.99K
Volume
115.64K
52-wk high
$7.75
52-wk low
$2.20
EPS
-$2.20
Shares outstanding
62.75M
No. of employees
48
Open
$4.30
High
$4.50
Low
$4.14
Mkt. cap
272.35M
Avg. vol.
269.99K
Volume
115.64K
52-wk high
$7.75
52-wk low
$2.20
EPS
-$2.20
Shares outstanding
62.75M
No. of employees
48
News stories
From web sources and news partners
Investing.com Nigeria
·
9 hours ago
CAMP4 receives UK authorization for SYNGAP1 trial of CMP-002 By Investing.com
Investing.com
·
13 hours ago
CAMP4 receives UK authorization for SYNGAP1 trial of CMP-002
Stock Titan
·
14 hours ago
A genetic disorder trial can now include UK sites. CAMP4 expects to start it in late 2026.
Investing.com
·
1 day ago
Camp4 Therapeutics at Cantor conference: pushing first SYNGAP1 trial
About CAMP4 Therapeutics Corp